Literature DB >> 18480824

Erectile dysfunction as a predictor of cardiovascular disease.

R A Kloner1.   

Abstract

Although it has been recognized that erectile dysfunction (ED) and coronary artery disease share many of the same risk factors--smoking, dyslipidemia, diabetes and hypertension--just in the past few years several new studies now suggest that ED is an important early marker of the presence of coronary artery disease. Recent analyses suggest that ED symptoms occur prior to coronary artery disease symptoms and may be a predictor of future major cardiovascular events. Some of these new studies also suggest that ED is an independent risk factor for predicting cardiovascular events--that is independent of other well-established risk factors. Taken together, these new studies suggest that when a patient presents with ED, the patient should be questioned about cardiac health and cardiovascular risk factors. If cardiovascular risk factors are identified, they should be worked up and aggressively treated--as treatment of these risk factors may be life-saving.

Entities:  

Mesh:

Year:  2008        PMID: 18480824     DOI: 10.1038/ijir.2008.20

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  12 in total

Review 1.  Should patients with erectile dysfunction be evaluated for cardiovascular disease?

Authors:  Kenneth A Ewane; Hao-Cheng Lin; Run Wang
Journal:  Asian J Androl       Date:  2011-11-28       Impact factor: 3.285

2.  The association of glomerular filtration rate and erectile dysfunction with severity of coronary artery disease in patients presenting with chest pain.

Authors:  Yalcin Solak; Hakan Akilli; Huseyin Atalay; Mehmet Kayrak; Hasan Gok; Suleyman Turk
Journal:  Int Urol Nephrol       Date:  2009-12-29       Impact factor: 2.370

3.  Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial.

Authors:  G David Batty; Qiang Li; Sébastien Czernichow; Bruce Neal; Sophia Zoungas; Rachel Huxley; Anushka Patel; Bastiaan E de Galan; Mark Woodward; Pavel Hamet; Stephen B Harrap; Neil Poulter; John Chalmers
Journal:  J Am Coll Cardiol       Date:  2010-11-30       Impact factor: 24.094

4.  COVID-19 and Male Sexual Functioning: A report of 3 Recovered Cases and Literature Review.

Authors:  Nader Salama; Saeed Blgozah
Journal:  Clin Med Insights Case Rep       Date:  2021-05-28

Review 5.  Addressing male sexual and reproductive health in the wake of COVID-19 outbreak.

Authors:  A Sansone; D Mollaioli; G Ciocca; E Limoncin; E Colonnello; W Vena; E A Jannini
Journal:  J Endocrinol Invest       Date:  2020-07-13       Impact factor: 4.256

6.  Gene expression profiling of mouse cavernous endothelial cells for diagnostic targets in diabetes-induced erectile dysfunction.

Authors:  Guo Nan Yin; Jiyeon Ock; Min Ji Choi; Anita Limanjaya; Kalyan Ghatak; Kang Moon Song; Mi Hye Kwon; Jun Kyu Suh; Ji Kan Ryu
Journal:  Investig Clin Urol       Date:  2020-11-09

Review 7.  COVID-19: systemic pathology and its implications for therapy.

Authors:  Qi Shen; Jie Li; Zhan Zhang; Shuang Guo; Qiuhong Wang; Xiaorui An; Haocai Chang
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

Review 8.  Erectile dysfunction and heart failure: the role of phosphodiesterase type 5 inhibitors.

Authors:  H Al-Ameri; R A Kloner
Journal:  Int J Impot Res       Date:  2009-04-23       Impact factor: 2.896

9.  Associations of Self-Reported Erectile Function with Non-Invasive Measurements of Endothelial Function: A Preliminary Study.

Authors:  Jong Kyou Kwon; Joo Yong Lee; Hae Do Jung; Cheol Kyu Oh; Young Deuk Choi; Kang Su Cho
Journal:  World J Mens Health       Date:  2015-12-23       Impact factor: 5.400

10.  Dietary flavonoid intake and incidence of erectile dysfunction.

Authors:  Aedín Cassidy; Mary Franz; Eric B Rimm
Journal:  Am J Clin Nutr       Date:  2016-01-13       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.